CEO of CytoDyn, Dr. Nader Pourhassan, Shares The Progress of The Company’s Leronlimab Trials with The Stock Day Podcast episode artwork

EPISODE · Oct 10, 2019 · 10 MIN

CEO of CytoDyn, Dr. Nader Pourhassan, Shares The Progress of The Company’s Leronlimab Trials with The Stock Day Podcast

from Stock Day Media · host Stock Day Media

The Stock Day Podcast welcomed CytoDyn Inc. (CYDY)(“the Company”), a biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. President and CEO, Dr. Nader Pourhassan, joined Stock Day host Everett Jolly.  Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Oct 10, 2019

Embed this episode

Ready to play

CEO of CytoDyn, Dr. Nader Pourhassan, Shares The Progress of The Company’s Leronlimab Trials with The Stock Day Podcast

0:00 10:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 10 minutes long.

When was this Stock Day Media episode published?

This episode was published on October 10, 2019.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!